Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2008
10/02/2008US20080241186 Nucleic acid vaccines for prevention of flavivirus infection
10/02/2008US20080241176 Incubating monocytes in nutrient broth comprising interleukins, cytokine and modified nucleotide sequences; propagate cells; recover antigen-presenting dendritic cell, contact with t-lymphocyte
10/02/2008US20080241175 Nucleotide sequences coding B7 immune response regulatory protein selectively expressed on dendritic cells for use as therapeutic tool in targeting viral and tumor cell for destruction
10/02/2008US20080241174 Lymphocyte which constitutively express cell surface markers CD4 and CD25, secretes cytokines interleukin-10 and interferon-gamma for use in ameloriating graft rejection and autoimmunity
10/02/2008US20080241172 Mutated Cholinesterase Sequences, Corresponding Nucleic Acids And Their Uses
10/02/2008US20080241171 Stem Cell Populations and Methods of Use
10/02/2008US20080241170 Increasing effectiveness of antigen cells expressing dendritic cell inhibitory receptor (DCIR); tissue targeted therapy
10/02/2008US20080241168 Transmembrane protein amigo and uses thereof
10/02/2008US20080241167 Inhibiting membrane fusion between human immunodeficiency virus and chemokine receptor-5 expressing cells using receptor specific immunoglobulins
10/02/2008US20080241166 Ligands that bind a receptor
10/02/2008US20080241160 Interleukin-4 specific immunoglobulin for use in treatment and prevention of atopic, respiratory and allergic disorders
10/02/2008US20080241158 G-protein coupled receptors for use in identifying modulators for treatment and prevention of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, metabolic and viral disorders
10/02/2008US20080241155 Death domain containing receptor 4
10/02/2008US20080241154 Isolation, Identification and Characterization of tmst2, a Novel Member of the TNF-Receptor Supergene Family
10/02/2008US20080241153 Vascular Endothelial Growth Factor C (VEGF-C) Protein and Gene, Mutants Thereof, and Uses Thereof
10/02/2008US20080241152 Vascular Endothelial Growth Factor C (VEGF-C) Protein and Gene, Mutants Thereof, and Uses Thereof
10/02/2008US20080241151 Neisserial peptides for use in developing vaccine for prevention and treatment of menigococcal septicemia and meningitis
10/02/2008US20080241150 Peptide comprising Lin12-Notch repeats (LNR) for use in identifying and designing modulators for prevention and treatment of cell proliferative disorders
10/02/2008US20080241149 Antibodies to complementary peptides of thrombin or portions thereof
10/02/2008US20080241147 Using pleckstrin homology (PH) domain-interacting protein as tool in detection and identification of modulators for prevention and treatment of cell proliferative disorders
10/02/2008US20080241146 Apo-2 ligand-anti-Her-2 antibody synergism
10/02/2008US20080241138 Soluble il-17ra/rc fusion proteins and related methods
10/02/2008US20080241137 Cancerous disease modifying antibodies
10/02/2008US20080241136 Using cc-chemokine receptor 2 (CCR2) specific immunoglobulins for use in treatment and prevention of skin disorders
10/02/2008US20080241134 Uses of human monoclonal antibodies against oxidized ldl receptor
10/02/2008US20080241133 Novel 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor
10/02/2008US20080241131 Using sphingosine kinase-2 as tool in identifying modulators for use in treatment of cell proliferative disorders
10/02/2008US20080241128 Antibodies; anticancer agents; autoimmune disorders
10/02/2008US20080241126 Nucleic acids encoding Human Engineered heavy and light chain variable region sequences to Ep-CAM
10/02/2008US20080241125 Muc1-ikb kinase complexes and their activities
10/02/2008US20080241114 Methods and compositions relating to modulation of hepatocyte growth, plasma cell differentiation or T cell subset activity by modulation of XBP-1 activity
10/02/2008US20080241113 Recovering and freezing stem cell collected during menses; tissue repair; regenerative medicine
10/02/2008US20080241112 Therapy of Kidney Diseases and Multiorgan Failure with Mesenchymal Stem Cells and Mesenchymal Stem Cell Conditioned Media
10/02/2008US20080241111 Pluripotent Stem Cell Derived from Cardiac Tissue
10/02/2008US20080241109 Using multimeric death receptor ligand as tumor targeting agent in treatment of cell proliferative disorders
10/02/2008US20080241107 Using transdifferentiated stem cells to treat diabetes; tissue engineering; regenerative medicine; tissue repair
10/02/2008US20080241106 Using nervous system protein to induce stem cell differentiation into pancreatic tissues; tissue engineering and repair; regenerative medicine;
10/02/2008US20080241103 Recombinant Virus Comprising an Intact Tumor-Therapeutic Antibody With Human Constant Regions and the Use Thereof
10/02/2008US20080241101 Nutrient broth comprising serine protease inhibitors and cytokine for use propgation of skin basement membrane tissues; regenerative medicine; tissue repair
10/02/2008US20080241098 Antagonizing interleukin-21 receptor activity
10/02/2008US20080241097 Methods of treating neurological conditions with hematopoeitic growth factors
10/02/2008US20080241096 IL-1 family variants
10/02/2008US20080241067 co-culturing cancer cells and host cells for a time sufficient to detect evidence of gene expression in co-culture for simulating the progression from a primary tumor to a metastasis in an in vitro model; anti-EphA2 ( epithelial cell kinase) antibody
10/02/2008US20080241062 Cancerous disease modifying antibodies
10/02/2008CA2719522A1 A non-destructive method to quantify and isolate antigen-specific b cells and uses thereof
10/02/2008CA2717659A1 Therapeutic applications of activation of human antigen-presenting cells through dectin-1
10/02/2008CA2684242A1 Somatic cell reprogramming
10/02/2008CA2682243A1 Methods and means for stem cell proliferation and subsequent generation and expansion of progenitor cells, as well as production of effector cells as clinical therapeutics
10/02/2008CA2681661A1 Methods of increasing nitrogen-assimilation capacity in transgenic plants expressing cca1 and glk1
10/02/2008CA2681144A1 Cancer disease modifying antibody 010207-01 produced by hybridoma cell line ar51a630.3.
10/02/2008CA2678901A1 Methods for modulating embryonic stem cell differentiation
10/02/2008CA2653967A1 Lyase enzymes, nucleic acids encoding them and methods for making and using them
10/02/2008CA2584758A1 Mix, some of best and novel cloning techniques
10/01/2008EP1975243A1 A method of isolating stem cells
10/01/2008EP1975231A1 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
10/01/2008EP1975183A1 Tumour-specific recognition molecules
10/01/2008EP1975182A1 CD40-binding APC-activating molecules
10/01/2008EP1974752A1 Subcellular targeting of therapeutic proteins
10/01/2008EP1974749A1 Cripto blocking antibodies and uses thereof
10/01/2008EP1974719A1 Conditioned medium and its uses
10/01/2008EP1974718A1 Cosmetic or dermatological composition comprising a cell culture medium
10/01/2008EP1974038A2 Nucleotide sequences and corresponding polypeptides conferring modulated plant growth rate and biomass in plants
10/01/2008EP1974032A2 Method for identifying a modulator of a cell signalling
10/01/2008EP1974028A2 Alpha-galactosidase from bifidobacterium bifidum and its use
10/01/2008EP1974026A2 Mutant deoxyadenosine kinase enzymes and their use
10/01/2008EP1974022A1 Mass producing method of growth factor using adipose derived adult stem cells
10/01/2008EP1974021A1 Maturation of dendritic cells.
10/01/2008EP1974020A1 Methods for obtaining immortalized antibody secreting cells
10/01/2008EP1974019A1 Use of adipose tissue derived mesenchymal stem cells for the treatment of graft versus host disease
10/01/2008EP1974018A2 Very small embryonic-like (vsel) stem cells and methods of isolating and using the same
10/01/2008EP1974017A1 Means and methods for influencing the stability of antibody producing cells
10/01/2008EP1974016A2 Mesenchymal stem cells and uses therefor
10/01/2008EP1974015A2 Biomimetic scaffolds
10/01/2008EP1974014A2 Oligopeptide-free cell culture media
10/01/2008EP1974013A2 Improved composition for collecting and preserving placental stem cells and methods of using the composition
10/01/2008EP1974012A2 Methods of improving stem cell homing and engraftment
10/01/2008EP1973950A2 Anti-ephb4 antibodies and methods using same
10/01/2008EP1973573A2 Methods and compositions for expanding t regulatory cells
10/01/2008EP1907565A4 Quantitative stabilized cell reference control products and methods
10/01/2008EP1812459A4 Method for the mass production of multimeric mannose binding lectin
10/01/2008EP1786910A4 Salt resistant transgenic plants
10/01/2008EP1709161B1 Human therapeutic cells secreting nerve growth factor
10/01/2008EP1633859B1 Cell line and uses thereof
10/01/2008EP1512740B1 Synthase of cereulide produced by bacillus cereus, gene encoding the same and method of detecting cereulide
10/01/2008EP1409659B1 Subtilase variants
10/01/2008EP1251172B1 Wt1-interacting protein wtip
10/01/2008EP1241933B1 Melanocortin-3 receptor deficient cells, transgenic mice and methods of selecting compounds which regulate body weight
10/01/2008EP1208111B1 Genes encoding insect odorant receptors and uses thereof
10/01/2008EP0764047B2 Polymeric microbeads and method of preparation
10/01/2008CN101278057A Cancerous disease modifying antibodies
10/01/2008CN101278056A Cancerous disease modifying antibodies
10/01/2008CN101278055A Cancerous disease modifying antibodies
10/01/2008CN101278049A Protoporphyrinogen oxidase having activity of imparting resistance against acifluorfen and gene thereof
10/01/2008CN101278045A Activating agent of stem cells and/or progenitor cells
10/01/2008CN101278044A Mutant cells suitable for recombinant polypeptide production
10/01/2008CN101277977A Cancerous disease modifying antibodies
10/01/2008CN101277728A Reinforcing agent for biological tissue, method of producing the same, utilization of the same and method of culturing cells
10/01/2008CN101277722A Composition and method for prevention and treatment of type I diabetes
10/01/2008CN101277610A Improved methods and means for producing hyaluronan
10/01/2008CN101275157A P21 promoter deacetylase inhibitor screening model and application thereof
1 ... 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 ... 1827